Diabetes, hepatitis virus infection and hepatocellular carcinoma

A case-control study in hepatitis endemic area

Wei Hsu Ko, Sherry Yueh Hsia Chiu, Kuo Ching Yang, Hsiu Hsi Chen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Aim: In spite of numerous studies on the association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC), the results are inconsistent and whether and how the effect of DM on the risk for HCC is modified or synergistically exerted by hepatitis virus infection are still unclear. We aimed to elucidate and quantify the effect modification and synergism between hepatitis B and C virus (HBV and HCV, respectively) and DM leading to the risk for HCC and also assess the independent contribution of DM to the risk for HCC at population level (population attributable fraction) in a high prevalence area of hepatitis virus infection. Methods: A hospital-based case-control study was conducted from one medical center. Information on hepatitis B and C virus infection and DM status (defined by 8-h fasting blood glucose level ≥126mg/dL, current use of oral hyperglycemic agent or insulin injection) was collected to assess interaction of hepatitis virus infection with DM on the risk for HCC. Results: The association between DM and the risk for HCC was significant regardless of the presence of HBV infection, whereas a significant positive association was noted for HCV negativity. Synergistic interactions between DM and HBV infection were significant. In the absence of both hepatitis virus infections, the independent effect of DM accounted for 7.5% risk for HCC from the underlying population. Conclusion: The effect of DM on the risk for developing HCC is higher in HCV negative patients and synergistic with HBV infection. The independent effect of DM provides a new insight to the prevention of HCC other than virus-related mechanism.

Original languageEnglish
Pages (from-to)774-781
Number of pages8
JournalHepatology Research
Volume42
Issue number8
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Hepatitis Viruses
Virus Diseases
Hepatitis
Case-Control Studies
Hepatocellular Carcinoma
Diabetes Mellitus
Hepatitis B virus
Hepacivirus
Infection
Population
Blood Glucose
Fasting
Insulin

Keywords

  • Diabetes mellitus
  • Hepatitis B virus
  • Hepatitis C virus
  • Hepatocellular carcinoma
  • Synergistic effect

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Cite this

Diabetes, hepatitis virus infection and hepatocellular carcinoma : A case-control study in hepatitis endemic area. / Ko, Wei Hsu; Chiu, Sherry Yueh Hsia; Yang, Kuo Ching; Chen, Hsiu Hsi.

In: Hepatology Research, Vol. 42, No. 8, 08.2012, p. 774-781.

Research output: Contribution to journalArticle

Ko, Wei Hsu ; Chiu, Sherry Yueh Hsia ; Yang, Kuo Ching ; Chen, Hsiu Hsi. / Diabetes, hepatitis virus infection and hepatocellular carcinoma : A case-control study in hepatitis endemic area. In: Hepatology Research. 2012 ; Vol. 42, No. 8. pp. 774-781.
@article{1246265ee9dc4002894cfb3fa15271f3,
title = "Diabetes, hepatitis virus infection and hepatocellular carcinoma: A case-control study in hepatitis endemic area",
abstract = "Aim: In spite of numerous studies on the association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC), the results are inconsistent and whether and how the effect of DM on the risk for HCC is modified or synergistically exerted by hepatitis virus infection are still unclear. We aimed to elucidate and quantify the effect modification and synergism between hepatitis B and C virus (HBV and HCV, respectively) and DM leading to the risk for HCC and also assess the independent contribution of DM to the risk for HCC at population level (population attributable fraction) in a high prevalence area of hepatitis virus infection. Methods: A hospital-based case-control study was conducted from one medical center. Information on hepatitis B and C virus infection and DM status (defined by 8-h fasting blood glucose level ≥126mg/dL, current use of oral hyperglycemic agent or insulin injection) was collected to assess interaction of hepatitis virus infection with DM on the risk for HCC. Results: The association between DM and the risk for HCC was significant regardless of the presence of HBV infection, whereas a significant positive association was noted for HCV negativity. Synergistic interactions between DM and HBV infection were significant. In the absence of both hepatitis virus infections, the independent effect of DM accounted for 7.5{\%} risk for HCC from the underlying population. Conclusion: The effect of DM on the risk for developing HCC is higher in HCV negative patients and synergistic with HBV infection. The independent effect of DM provides a new insight to the prevention of HCC other than virus-related mechanism.",
keywords = "Diabetes mellitus, Hepatitis B virus, Hepatitis C virus, Hepatocellular carcinoma, Synergistic effect",
author = "Ko, {Wei Hsu} and Chiu, {Sherry Yueh Hsia} and Yang, {Kuo Ching} and Chen, {Hsiu Hsi}",
year = "2012",
month = "8",
doi = "10.1111/j.1872-034X.2012.00979.x",
language = "English",
volume = "42",
pages = "774--781",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Diabetes, hepatitis virus infection and hepatocellular carcinoma

T2 - A case-control study in hepatitis endemic area

AU - Ko, Wei Hsu

AU - Chiu, Sherry Yueh Hsia

AU - Yang, Kuo Ching

AU - Chen, Hsiu Hsi

PY - 2012/8

Y1 - 2012/8

N2 - Aim: In spite of numerous studies on the association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC), the results are inconsistent and whether and how the effect of DM on the risk for HCC is modified or synergistically exerted by hepatitis virus infection are still unclear. We aimed to elucidate and quantify the effect modification and synergism between hepatitis B and C virus (HBV and HCV, respectively) and DM leading to the risk for HCC and also assess the independent contribution of DM to the risk for HCC at population level (population attributable fraction) in a high prevalence area of hepatitis virus infection. Methods: A hospital-based case-control study was conducted from one medical center. Information on hepatitis B and C virus infection and DM status (defined by 8-h fasting blood glucose level ≥126mg/dL, current use of oral hyperglycemic agent or insulin injection) was collected to assess interaction of hepatitis virus infection with DM on the risk for HCC. Results: The association between DM and the risk for HCC was significant regardless of the presence of HBV infection, whereas a significant positive association was noted for HCV negativity. Synergistic interactions between DM and HBV infection were significant. In the absence of both hepatitis virus infections, the independent effect of DM accounted for 7.5% risk for HCC from the underlying population. Conclusion: The effect of DM on the risk for developing HCC is higher in HCV negative patients and synergistic with HBV infection. The independent effect of DM provides a new insight to the prevention of HCC other than virus-related mechanism.

AB - Aim: In spite of numerous studies on the association between diabetes mellitus (DM) and hepatocellular carcinoma (HCC), the results are inconsistent and whether and how the effect of DM on the risk for HCC is modified or synergistically exerted by hepatitis virus infection are still unclear. We aimed to elucidate and quantify the effect modification and synergism between hepatitis B and C virus (HBV and HCV, respectively) and DM leading to the risk for HCC and also assess the independent contribution of DM to the risk for HCC at population level (population attributable fraction) in a high prevalence area of hepatitis virus infection. Methods: A hospital-based case-control study was conducted from one medical center. Information on hepatitis B and C virus infection and DM status (defined by 8-h fasting blood glucose level ≥126mg/dL, current use of oral hyperglycemic agent or insulin injection) was collected to assess interaction of hepatitis virus infection with DM on the risk for HCC. Results: The association between DM and the risk for HCC was significant regardless of the presence of HBV infection, whereas a significant positive association was noted for HCV negativity. Synergistic interactions between DM and HBV infection were significant. In the absence of both hepatitis virus infections, the independent effect of DM accounted for 7.5% risk for HCC from the underlying population. Conclusion: The effect of DM on the risk for developing HCC is higher in HCV negative patients and synergistic with HBV infection. The independent effect of DM provides a new insight to the prevention of HCC other than virus-related mechanism.

KW - Diabetes mellitus

KW - Hepatitis B virus

KW - Hepatitis C virus

KW - Hepatocellular carcinoma

KW - Synergistic effect

UR - http://www.scopus.com/inward/record.url?scp=84863749909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863749909&partnerID=8YFLogxK

U2 - 10.1111/j.1872-034X.2012.00979.x

DO - 10.1111/j.1872-034X.2012.00979.x

M3 - Article

VL - 42

SP - 774

EP - 781

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 8

ER -